Suchergebnisse - "Musto, Pellegrino"

PubPharm (762)

1

Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia : a randomized trial

enthalten in: Blood advances | 2024

von Mazzucconi, M. | Rodeghiero, F. | Avvisati, G. | +37

2

A stable and sensitive 2D SERS sensor for bioanalytical applications

enthalten in: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy | 2024

von Pannico, M. | Musto, P.

3

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

enthalten in: Blood | 2024

von D'Agostino, M. | Bertuglia, G. | Rota-Scalabrini, D. | +22

CommentIn: Blood. 2024 Feb 15;143(7):564-566. - PMID 38358852

4

Antibody Response to Breakthrough SARS-CoV-2 Infection in "Booster" Vaccinated Patients with Multiple Myeloma According to B/T/NK Lymphocyte Absolute Counts and anti-CD38 Treatments

enthalten in: Mediterranean journal of hematology and infectious diseases | 2024

von Sgherza, N. | Mestice, A. | Larocca, A. | +1

5

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P. | Dimopoulos, M. | Boccadoro, M. | +141

CommentIn: N Engl J Med. 2024 Apr 18;390(15):1440. - PMID 38631009

6

Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort

enthalten in: American journal of hematology | 2024

von Gurnari, C. | Pascale, M. | Vitale, A. | +42

7

Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic : Results from the EPICOVIDEHA registry

enthalten in: Hematological oncology | 2024

von Musto, P. | Salmanton-García, J. | Sgherza, N. | +84

8

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma : a multicenter, retrospective, real-world experience with 200 cases outside of controlled clinical trials

enthalten in: Haematologica | 2024

von Gentile, M. | Vigna, E. | Palmieri, S. | +44

9

Clinical outcome of breakthrough COVID-19 in multiple myeloma patients after three or more anti-SARS-CoV-2 vaccine doses : a single center analysis of 64 cases

enthalten in: Annals of hematology | 2024

von Sgherza, N. | Curci, P. | Rizzi, R. | +7

10

Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort

enthalten in: American Journal of Hematology | 2024

von Gurnari, C. | Pascale, M. | Vitale, A. | +42

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[77]